Actualités

eBay will report its Q2 results soon. Here’s what analysts expect out of it…

PepsiCo Inc (NASDAQ:PEP, XETRA:PEP) shares fell about 4% on Thursday after the food and beverage company reported fiscal second-quarter adjusted earnings that came in slightly below Wall Street expectations, despite revenue topping estimates and the company reaffirming its full-year...

Bank of America and Wells Fargo are entering Q2 earnings with improving fundamentals, but solid earnings momentum and estimate revisions give one bank an edge.

PepsiCo stock was falling Thursday after the soft drinks and snacks maker said it had lost market share in North America, overshadowing a second-quarter earnings beat. The maker of Lay’s, Doritos, Pepsi, and Gatorade reported an adjusted profit of $2.20 a share for the second quarter, as revenue climbed 6.4% from a year ago to $24.18 billion. Analysts were expecting adjusted earnings of $2.19 a share on revenue of $23.95 billion, according to a FactSet poll.

PEP beats on Q2 earnings on a rise in organic revenues, improved volumes and solid international growth, offsetting margin pressure and North America softness.

Nexa Resources expects to keep its 2026 zinc guidance intact despite the impacts of the Cajamarquilla fire, with lost refined zinc output set for recovery in H2.

Ford will release its Q2 earnings report later this month, and analysts forecast a single-digit decline in the bottom line.

WFC heads into Q2 earnings release with expected gains in NII and fee income, but can stronger revenues offset provisions and mortgage banking pressure?

Amgen trades at $365.22 per share and has stayed right on track with the overall market, gaining 12% over the last six months. At the same time, the S&P 500 has returned 7.7%.

Initial Claims came in at +215K, right where they were a week ago, and Continuing Claims also came in precisely where last week's original print did: +1.814 million.

David Joyner’s assurances, which come about a month before CVS is scheduled to report its second quarter results, will likely be welcomed by investors wary after a difficult few years for insurers.

Cigna is scheduled to post its second-quarter results later this month, and analysts project a single-digit earnings growth.

Limbach has been treading water for the past six months, recording a small loss of 1.9% while holding steady at $77.06. The stock also fell short of the S&P 500’s 7.7% gain during that period.

Huntington Ingalls is set to announce its second-quarter earnings soon, and Wall Street expects a low single-digit decline in its profit.

GE (GE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

With PepsiCo (NASDAQ:PEP) set to report Q2 2026 earnings before the market opens on July 9, 2026, investors are asking whether to buy the beverage and snacks giant ahead of the earnings report. Our 24/7 Wall St. price target for PepsiCo is $171.20, implying 18.09% upside from $144.98. Our recommendation is a buy, with a ... PepsiCo Price Prediction: Is The Stock a Buy Before Earnings?

According to Koyfin data, the consensus revenue estimate for Delta Air Lines stands at $18.85 billion, and adjusted earnings per share are expected to be $1.50.

Although the revenue and EPS for PepsiCo (PEP) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HELE tops fiscal first-quarter estimates, lifts fiscal 2027 sales outlook and sees net sales rise on growth across Home & Outdoor and Beauty & Wellness.

Byrna Technologies (BYRN) delivered earnings and revenue surprises of -340.00% and -28.46%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Beyond analysts' top-and-bottom-line estimates for Citigroup (C), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Bank of America (BAC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

Get a deeper insight into the potential performance of Goldman (GS) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Monolithic Power Systems will release its second-quarter earnings soon, and analysts anticipate a double-digit bottom-line growth.

Xylem will release its second-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth.

July is shaping up to be the pivotal month for cloud computing investors in 2026. All three of the companies below report late-July results with their cloud franchises accelerating, not decelerating, into the print. Enterprise AI workloads are still running ahead of supply, hyperscaler backlogs are ballooning, and the market has already begun to sort ... 3 Cloud Computing Stocks to Buy Before Earnings Season in July

Over the past six months, Howard Hughes Holdings’s shares (currently trading at $72.86) have posted a disappointing 11.8% loss, well below the S&P 500’s 7.7% gain. This might have investors contemplating their next move.

Investing.com -- A major AI team-up wasn’t enough to cushion the blow for Rackspace Technology (NASDAQ:RXT). Shares plummeted over 10% Thursday after the cloud operator severely dialed back its fiscal 2026 revenue projections, completely overshadowing a high-profile strategic partnership with Palantir Technologies (NASDAQ:PLTR) announced earlier in the day. The San Antonio-based enterprise AI infrastructure provider aggressively trimmed its fiscal 2026 revenue guidance to a range of $2.45 billio

Honeywell Technologies made a big adjustment to its financial guidance. The automation company said late Wednesday that it now expects full-year earnings per share of between $7.90 and $8.30, from a prior range of $3.95 to $4.15. Investors should remember that Wall Street analysts don’t update numbers every day.

Biogen is poised to announce its second-quarter results later this month, and analysts predict a double-digit drop in the company’s bottom-line figure.